The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: Sleep Treatment Education Program-1 (STEP-1)
Official Title: Sleep Treatment Education Program (STEP-1): An Online Educational Intervention for Insomnia in Cancer Survivors
Study ID: NCT05519982
Brief Summary: The purpose of the study is to learn if single session online education programs can help improve cancer survivors' sleep.
Detailed Description: This study is a randomized controlled trial of cancer survivors with clinically significant symptoms of insomnia to evaluate the efficacy of the cognitive-behavioral intervention Sleep Treatment Education Program-1 (STEP-1). Participants in this study will be randomized to either the behavioral education session, Sleep Treatment Education Program-1 (STEP-1), which will instruct them on how to make changes to their sleep habits and behaviors or an enhanced usual care control program which will provides them with access to online relaxation programs and instruct them about how these programs can help improve sleep. Participation in the study involves: * Taking part in a 60-90 minute, one-on-one session using the Zoom video conference platform and completing a brief online questionnaires. * Completing an approximately 10 minute follow-up questionnaire online with a brief phone call 4, and 8 weeks after the education session. An additional optional insomnia questionnaire will be requested at one month after the 8 week follow-up. * Participants will receive a $25 gift card upon completing 4 \& 8 week questionnaires. It expected that about 70 people will take part in this study.
Minimum Age: 40 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Dana Farber Cancer Institute, Boston, Massachusetts, United States
Name: Christopher Recklitis, PhD, MPH
Affiliation: Dana-Farber Cancer Insitute
Role: PRINCIPAL_INVESTIGATOR